29
April 2024
Christie Group
plc
Preliminary results for the 12 months ended 31 December
2023
A challenging 2023 but a more
encouraging outlook for 2024
Christie Group plc ('Christie Group'
or the 'Group'), the leading provider of Professional &
Financial Services (PFS) and Stock & Inventory Systems &
Services (SISS) to the hospitality, leisure, healthcare, medical,
childcare & education and retail sectors, is pleased to
announce its audited preliminary results for the 12 months ended 31
December 2023.
FY23 Headlines:
· Revenue down 4.8% to £65.9m (2022: £69.2m)
· Operating loss before non-recurring costs of £0.6m (2022:
profit £5.4m)
· Non-recurring costs attributable to board changes and
restructuring of £2.7m (2022: £nil)
· PFS
revenues down £5.1m to £42.2m (2022: £47.4m) as transactional
brokerage incomes were impacted by rising interest rate rises and
inflation
· UK
transactional pipelines have recovered and ended the year 27%
higher than the prior year
· SISS
revenues up by 8.4% to £23.6m (2022: £21.8m) but division remained
loss-making
· The
Group ended 2023 with net funds of £0.6m (2022: £7.2m)
· CLBILS
loan was fully repaid in June 2023
· Elimination of pension deficits on both defined pension
schemes which both remain in surplus
· Final
dividend reduced to 0.50p (2022: 2.50p) to give total in year of
1.00p (2022: 3.75p) reflecting the challenging year but also the
more positive outlook for the business
2024 Outlook:
· The
Group is well positioned for an improved performance in 2024 with
opportunities for growth across all business sectors, in the UK and
internationally.
· Current activity levels are encouraging, with our UK
transactional brokerage pipelines strongly ahead of this time last
year and our finance brokerage business experiencing strong
demand
Commenting on the results, Dan Prickett, Chief Executive of
Christie Group said:
"2023 was a challenging
and extremely disappointing year for the Group as the effects of
continual increases in interest rates and high inflation led to a
significant reduction in the volume of business sales. However, our
recovery is in progress and activity levels are encouraging, with
our UK transactional brokerage pipelines now strongly ahead of this
time last year and our finance brokerage business experiencing
strong demand. Nonetheless, the expected timing of many of those
transactions points to a second-half weighting to our 2024
performance."
Enquiries:
Christie Group plc
|
|
Daniel Prickett
Chief Executive
Simon Hawkins
Chief Financial Officer
|
07885 813101
07767 354366
|
|
|
Shore Capital
Patrick Castle
Nominated Adviser &
Broker
|
020 7408 4090
|
Notes to Editors:
Christie Group plc (CTG.L),
quoted on AIM, is a leading professional business services group
with 37 offices across the UK and Europe, catering to its
specialist markets in the hospitality, leisure, healthcare,
medical, childcare & education and retail sectors.
Christie Group operates in
two complementary business divisions: Professional & Financial
Services (PFS) and Stock & Inventory Systems & Services
(SISS). These divisions trade under the brand names: PFS
- Christie & Co, Pinders, Christie Finance and
Christie Insurance: SISS - Orridge, Venners and
Vennersys.
Tracing its origins back to 1846,
the Group has a long-established reputation for offering valued
services to client companies in agency, valuation services,
investment, consultancy, project management, multi-functional
trading systems and online ticketing services, stock audit and
inventory management. The diversity of these services provides a
natural balance to the Group's core agency business.
The information contained within
this announcement is deemed by the Company to constitute inside
information for the purposes of Article 7 of the UK Market Abuse
Regulation (EU) No. 596/2014 which is part of the UK law by virtue
of the European Union (Withdrawal) Act 2018.
For more information, please go
to
www.christiegroup.com.
CHAIRMAN'S REVIEW OF THE YEAR
Having recovered strongly
in 2022 from the effects of Covid in 2020 and 2021, the Group's
performance in 2023 was both disappointing and frustrating. The
2023 result was shaped by a sharp decline in transaction volumes in
our main agency business, as a result of rising interest rates and
widespread decline in business confidence in the UK economy
following the mini budget of autumn 2022. The impact persisted
until the end of the summer period before we saw signs of a return
to more normal conditions in the latter part of the year.
Consequently, we ended the year with far stronger forward-looking
pipelines than those at the beginning of the year.
In our stocktaking division, the
departure from the high street of the Wilko retail chain had a
major impact on our Orridge business, although we made encouraging
progress in the continuing post-Covid recovery of our hospitality
stocktaking business.
As a result of this extremely
challenging trading environment, our first half performance was
acutely affected. H1 revenue fell versus the previous year which,
combined with an increased operating cost base, meant that we
reported an operating loss over the first six months of £1.4m. This
H1 loss was partially mitigated by a better H2 performance,
generating a £0.8m operating profit pre
non-recurring board changes and restructuring
costs, reducing our full-year loss to
£0.6m.
The table below sets out a summary
of the year's results. The Chief Executive's Review provides a
comprehensive commentary, but the headline figures show that we
achieved revenues of £65.9m, against £69.2m in the prior year,
delivering an operating loss pre
non-recurring board changes and restructuring costs
of £0.6m, versus an operating profit of £5.5m in
2022. Our loss before tax was £4.3m, in comparison to a profit
before tax of £4.4m last year.
|
2023
|
2022
|
|
£'000
|
£'000
|
Revenue
|
65,873
|
69,192
|
Operating (loss)/profit pre
non-recurring board changes & restructuring costs
|
(632)
|
5,452
|
Non-recurring board changes and
restructuring costs
|
(2,723)
|
-
|
Operating (loss)/profit post
non-recurring board changes &restructuring costs
|
(3,355)
|
5,452
|
Finance costs
|
(928)
|
(1,028)
|
(Loss)/profit before tax
|
(4,283)
|
4,424
|
|
|
|
Net assets
|
3,301
|
8,396
|
Cash and cash equivalents
|
1,336
|
8,839
|
|
|
|
(Losses)/earnings per share -
Basic
|
(14.79)
|
12.32
|
Final dividend (pence per
share)
|
0.50
|
2.50
|
Full year dividend (pence per
share)
|
1.00
|
3.75
|
Despite the volatility of 2023, we
chose to keep our businesses well-resourced based on the
expectation that transaction volumes would recover to more
normalised levels in 2024. Early indications are proving this to
have been the right strategic decision. We ended the year with
positive net cash funds, without any term debt, having fully repaid
the CLBILS loan taken out during Covid and with our two defined
benefit pension schemes in surplus.
We are confident that the Group and
its businesses are well prepared to deliver on our goals in the
year ahead. Our fundamentals are sound, with a robust balance sheet
and proven track record of resilience in our businesses. Our
markets and clients need our services, with our Professional &
Financial Services ("PFS") clients requiring the best possible
advice on areas including property, finance, insurance, valuation
and business management. Likewise, as technological and
geo-political factors transform and disrupt our clients' supply
chains and their own consumers' habits evolve further, we
anticipate growing demand for the dependability, speed, accuracy
and reliability of our Stock & Inventory Systems & Services
("SISS") professionals and software.
Environmental, Social & Governance
The Board recognises the importance
of strong corporate governance, and we comply with the Quoted
Companies Alliance (QCA) Governance Code. We agree with the common
listed company convention that governance is enhanced by the
separation of the roles of Chair and Chief Executive. The Board has
therefore taken the opportunity through the board changes in July
to comply with listed company market norms and is now committed to
maintaining an independent Non-Executive Chair and a Chief
Executive as two sperate roles in the future.
On the wider subject of ESG, notably
the Environment and Social aspects, we are at an early stage of a
process across our Group to assess our plans to address our ESG
issues in the context of what is meaningful to us, our stakeholders
and our business aspirations. As a collection of service
businesses, our environmental impact is relatively limited, but
there are undoubtedly improvements we can make to reduce our carbon
footprint of our teams during the years ahead by, for example
changing the way we work and travel. Socially, we are keen to
further enhance our status as an employer of the most talented
individuals from diverse, international backgrounds. We already
support a wide range of sectors which are themselves vital to the
economy and wider society. Our businesses also increasingly
recognise the benefits of supporting employee wellbeing initiatives
that are vital to ensuring our teams can continue to provide our
clients with the service and skill levels that they have come to
expect. Our Group and its businesses have a long-standing track
record of supporting a variety of charitable endeavours, and we
intend for this to continue.
I would personally like to thank the
Board for their confidence in appointing me as Interim
Non-Executive Chair while the search to recruit a permanent
successor continues. My gratitude also goes to every member of the
Christie Group team for their continued commitment to the business
during what has been a difficult year, and I look forward to seeing
them raise their game again to deliver their plans and navigate the
inevitable challenges ahead. The extraordinary competence and
commitment of our people and the strength of our long-term client
relationships are regularly endorsed by positive feedback and the
repeat use of our services.
On behalf of the Board, I would also
like to congratulate Dan Prickett on his promotion to Chief
Executive of the Christie Group and we wish him every success in
his new role.
Looking ahead
We believe that the Group and our
businesses are well positioned to improve their performance during
the coming year. We see opportunities for growth across all
business sectors, in the UK and internationally.
The Board is of course cognisant of
the uncertainties resulting from external factors such as
inflation, interest rates, potential political changes and
heightened global geopolitical risk, particularly during 2024.
These will provide challenges for many companies, and Christie is
not immune. However, we believe that the diversified nature of
services provided by the Christie Group provide a defensive,
resilient structure, which will better enable us to manage and
weather the macroeconomic challenges ahead. Broadening and
enhancing our strengths and capabilities across our international
network will also further assist us in this respect.
The Board believes that
opportunities for stronger performance do lay ahead. We have seen
indications of improvement towards last year's end, a more
encouraging economic situation taking shape and positive indicators
in several of our target markets. We are therefore recommending a
final dividend of 0.50p, to be approved at our AGM on Thursday 13
June 2024. Subject to that approval, the dividend is set for
payment on 12 July 2024 to those shareholders on the register on 14
June 2024.
Simon Herrick
Non-executive
Interim Chairman
26 April 2024
CHIEF EXECUTIVE'S REVIEW
2023 was clearly a very challenging
year for the Group, with the final outcome far below the
aspirations we began the year with. The acutest impact was on our
transactional brokerage revenues within our Professional &
Financial Services ("PFS") division, where the effects of continual
and rapid increases in interest rates - combined with an
uncomfortable inflationary environment for vendors and prospective
purchasers - meant that we saw the volume of business sales
significantly reduced from the previous year and the expectations
for 2023 curtailed accordingly.
Deals being delayed, repriced,
paused or elongated on a scale not experienced before - but in many
cases without resulting in withdrawn instructions on which we could
form definitive views - made forecasting deal timing and outcomes
extremely challenging, arguably more so than at any time since the
global financial crisis. Similar challenges were reported by a
number of competitors during the year.
Encouragingly, we saw a much
improved level of brokerage invoicing from September onwards, while
at the same time new instruction levels also improved. As such, we
ended 2023 with a UK transactional pipeline 27% above the same
point a year earlier, indicating cause for optimism as we began
2024. Based upon management's view that 2023 was likely to be a
transient period of market adjustment, we retained and invested in
our PFS division workforce, so that we were positioned to take
advantage of the opportunities we see in our sectors and services
moving forwards.
Financial performance summary
The result was full year total
revenue of £65.9m, which represented a 4.7% reduction from the
prior year (2022: £69.2m), and an operating loss pre non-recurring
board changes and restructuring costs of £0.6m (2022: £5.5m
operating profit).
Within this, the £5.1m fall in PFS
revenues to £42.3m (2022: £47.4m) combined with a continuing
investment to both retain and strengthen our teams and capabilities
for the medium and longer term, meant that PFS operating profit
fell from £7.6m in 2023 to £1.3m pre non-recurring board changes
and restructuring costs.
Stock & Inventory Systems &
Services ("SISS") revenues grow by 8.4% to £23.6m (2022: £21.8m).
This growth was driven by a strong and continued recovery by our
hospitality stock audit business, which grew its own revenues by
nearly 15%. Unfortunately, this positive performance was offset by
further challenges in our retail stocktaking operations and the
delayed revenue impact of new business wins otherwise achieved in a
more positive year for our SaaS business, Vennersys. As such SISS
operating losses pre non-recurring board changes and restructuring
costs were only reduced slightly to £2.0m (2022: £2.1m), but
with an expectation that the division will perform far more
strongly in 2024, operating from a more efficient cost
base.
In addition to the costs associated
with the Board changes previously reported in July, we have
incurred further non-recurring board changes and restructuring
costs in H2. In our PFS division, we have exited from our Finland
operation where the changed political environment and reduced
Baltic investment opportunities meant that we could not see
potential for scalable agency or advisory operations in the region.
In our UK retail stocktaking business, we reacted to the
administration of one larger client, Wilkos, by streamlining our
operating cost base, and we also completed the exit from the legacy
office of our now-ceased Canadian ticketing software activities.
Total non-recurring board changes and restructuring costs in the
period therefore amounted to £2.7m (2022: £nil).
Cash and balance sheet
We ended the year with net funds and
free of any term-debt, having completed the full repayment in June
2023 of the £6.0m CLBILS loan we borrowed in mid-2020. Our working
capital management remains robust, both in terms of our own
collection of amounts due to us and timely payment of our own
suppliers.
We are pleased to have followed the
elimination of both defined benefit schemes' deficits with decisive
changes in investment strategy adopted by the two sets of trustees.
These changes, implemented across the year end, are intended to
ensure the Group is protected from being required to make deficit
repair payments in future through a greater level of investment in
high grade bonds and gilts, whose own value measurement should more
closely correspond to any change in scheme liabilities. We are
optimistic this will avoid any future funding shortfall while we
continue to explore further de-risking options.
Professional & Financial Services
Division
As the effects of fourteen
consecutive increases in the UK base rate took effect, our agency
and advisory business, Christie & Co, saw transactional volumes
reduce by 22% on the previous year. Those same economic conditions
also served to subdue the value of businesses in our sectors and
therefore created downward pressure on the related agency fees for
our brokerage services.
The business carried some momentum
into the early part of the year from a pipeline of work largely
created prior to the October 2022 mini-budget, but after those
deals were brought to exchange in the first quarter, we experienced
a fallow second and third quarters before activity levels began to
normalise post-summer. We are optimistic that period is now behind
us, with transactional pipelines restored to far healthier levels
by the end of 2023. Work remains ongoing on a number of significant
multi-asset disposal campaigns, selling packages of between 30 and
100 properties on a break-up basis, at which Christie & Co
excels. We also made further progress in the development of our
newer sector specialisms, notably our Garden Centres and Caravan
& Holiday Park teams.
Distressed instructions began to
return as a more prominent feature of our assignments.
Approximately 10% of all agency instructions received in 2023 by
our UK business had some form of distress and we expect to see that
continue into 2024.
Our international network benefitted
from an excellent year by our French team, who completed 23 hotel
transactions in the year as our standout performer. We established
a Healthcare transactional team in Frankfurt and we aim to expand
this outside of Germany, as we seek to evolve our European
operations into operations of applicable multi-sector capability
where for over 20 years we have been Hotels focused on the
continent.
Our Business Appraisal operation,
Pinders, delivered an excellent full year outcome after a slow
start to the year. Activity picked up sharply in the spring, with
demand for valuations in the white coat sector particularly strong,
aided by instructions connected to the disposal by LloydsPharmacy
of its retail arm. The number of pharmacies valued by Pinders in
2023 was 77% higher than the previous year, but the increased
concentration on White Coat sector assignments had the effect of
subduing average fee growth. Pinders also had an encouraging and
progressive year in terms of recruitment and graduate training, and
it continues to focus on growing its Building Services and Dispute
Resolution fee income.
In aggregate, Christie & Co and
Pinders valued assets worth £9.4bn in the year (2022: £10.1bn).
Both businesses' reputations among lenders remain very strong,
sustaining all of their lender panel positions and achieving
service delivery times that most competitors cannot
rival.
Our finance brokerage business,
Christie Finance, delivered increased deal volume and turnover, but
itself suffered from similar conditions to Christie & Co where
commercial mortgage lending was subdued at the start of the year
and gathered momentum gradually amidst the continual changes in
lending conditions, before a frustrating end to the year saw some
expected offers of finance - the trigger point at which we
recognise brokerage commission - being delayed into 2024 in both
our Core and Corporate divisions. This more subdued activity level
at the start of 2023 was illustrated by a 13% reduction in the
number of loan offers secured, but this was offset by a higher
ratio of secured offers being converted into drawn-down borrowing
by clients.
Nonetheless, the total value of debt
secured for clients across the Christie Finance business increased
by 20% to over £183m, with the strongest growth coming in its
Unsecured lending team who increased completed deal volumes by 48%
on 2022 levels. Christie Finance also established a specialist Real
Estate division to offer finance for bridging, property investment
and development funding and we are encouraged by the initial levels
of activity achieved with plans to further expand that team in
2024.
Recognising the potential for growth
in our finance brokerage operation, we grew fee earning headcount
in the business by 24% in the year and will seek to continue that
trend in the year ahead.
As part of our commitment to the
further development and growth of our financial services
capabilities, we also took the decision to invest in our insurance
brokerage business, Christie Insurance, to enable us to fully
benefit from the strong levels of cross referral potential which
remain inherent in the wider Christie Group companies' client base.
We completed the process to achieve full FCA approval for
conducting directly regulated insurance brokerage business in June
2023, and that enabled us to move away from the brokerage
outsourcing model we had used since 2013 and better align our
service and growth culture with those seen elsewhere in our PFS
division.
As a result, we commenced our
directly regulated insurance activities on 1 October 2023. As part
of this strategy, we have invested in expanding our insurance
brokerage team in the second half and expect to have completed our
initial recruitment program by the end of H1 2024, better enabling
us to achieve our ambitions of sustainably growing our book of
recurring renewal general insurance clients while also being able
to provide customers with a suite of life assurance and other
protection products.
PFS
divisional KPIs
|
2023
|
2022
|
Total businesses sold
|
820
|
1,057
|
% Increase / (decrease) in average
fee per business sold
|
(2.04)%
|
14.4%
|
Total value of businesses sold
(£m)
|
1,037
|
1,493
|
Total valuations carried out
(units)
|
5,291
|
5,515
|
% increase in average fee per
valuation
|
5.6%
|
0.7%
|
Value of businesses valued
(£m)
|
9,417
|
10,057
|
% (decrease) / increase in number of
loan offers secured
|
(12.8%)
|
4.2%
|
Average loan size (£'000)
|
624
|
440
|
Stock & Inventory Systems & Services
Division
Our hospitality stock audit and
consultancy business, Venners, performed well. Strong progress was
made in expanding its stocktaker resources through a successful
recruitment and training effort. This was as part of a holistic
focus on staff retention and development aimed at ensuring its
recruitment needs are not exacerbated by retention challenges. The
business ended 2023 with its stocktaker headcount increased by 16%
from a year earlier. As the recruitment success was more
second-half weighted, the annualised benefit of this growth will
only be fully seen in 2024.
Further recruitment is planned for
the current year to enable the business to continue to address
healthy levels of demand for its services.
The strength of demand for Venners'
services was reflected by a record year in terms of new business
quoting activity, exceeding what had previously been a record year
in 2022. Average fees were increased by over 8%, necessitated by
the continued inflationary pressures on operating costs, but
excellence of service and a market-leading reputation meant the
business was successful converting over 50% of all quotes issued
into new business wins. Notable additions in the year to our client
portfolio included Rangers FC, The Savoy Hotel, London and Popeye's
Louisiana Kitchen franchise operation.
Encouragingly the business also made
good progress in increasing its higher-margin Consultancy and
Compliance revenues. The latter saw a year-on-year growth in volume
of work undertaken of 15%, while the former had a record year in
terms of revenues and more than doubled its 2022 revenue
levels.
Our pan-European retail and pharmacy
stocktaking business, Orridge, experienced a mixed year. In our UK
retail operation, the largest constituent of the Orridge group of
businesses, new business sales were much improved on recent years
and saw clients such as The British Heart Foundation, Iceland,
Hamleys of London and Gym Shark added. However, the administration
of Wilkos in August meant the business lost a valued client from
its portfolio and we sought to mitigate that effect and better
align our operating cost base with future expected revenues by
completing appropriate restructuring in the second half of the
year.
Conversely, our Pharmacy stocktaking
business had an excellent year, increasing revenues 60% on 2022
levels and improving its margins in the process as it benefitted
from growth in its recurring client base and its ability to carry
out stock valuations in an eventful year for the UK Pharmacy
sector.
Our Supply Chain business also grew
revenues by over 40% year-on-year while achieving similar margin
levels to Pharmacy. In our European operations, we made good
progress in Germany with 21% revenue growth, but found it more
challenging in our Benelux operation where cost inflation and
higher levels of staff churn were disruptive.
Vennersys, our Software-As-A-Service
("SaaS") provider to UK visitor attractions, delivered a
significantly improved 2023 compared to 2022 in terms of new client
wins, securing over 30 new wins, albeit with some of those
installations scheduled for 2024. It also began 2024 with a
pipeline of actively engaged opportunities that provides the
visible potential to match or exceed that level of new business
growth in the year ahead.
Disappointingly, the business
suffered some client attrition, albeit very limited in terms of
client numbers, but which prevented it from growing its revenues
overall. Encouragingly, the percentage of visitors to our clients
choosing to purchase their tickets online increased slightly
year-on-year.
We have continued to invest in the
VenPos Cloud product, developing it in several areas which include
the addition of Digital Wallets, Kiosk facilities for food &
beverage outlets within attractions and an improved on-line journey
for customers.
SISS divisional KPIs
|
2023
|
2022
|
Total stocktakes & audits
carried out (number of jobs)
|
54,199
|
53,818
|
% increase in average income per
job
|
7.9%
|
4.7%
|
% of visitor attraction client
admissions purchased online
|
47.7%
|
45.3%
|
Looking ahead
We ended 2023 disappointed by the
full year performance, but encouraged by the improved activity that
we saw as we moved through the final quarter of the year and by the
recovery in the transactional pipelines being carried into 2024.
Despite the wider market difficulties, our businesses continue to
attract notable instructions from clients across our sectors who
recognise and value the quality of the service we provide and the
outcomes we can deliver. We will continue to build on those
strengths. Activity across all of our sector teams at the start of
2024 has been positive, as we look to bounce back swiftly from a
challenging twelve months. In our agency and advisory business, UK
transactional pipelines have continued to strengthen and compare
favourably at the end of Q1 2024 to the same point a year ago, but
the expected timeline against many of those transactions points
once again to a second-half weighting to our PFS
revenues.
We have broadened our international
agency and advisory business through the addition of a second
sector capability in Germany, and we will look to replicate that
multi-sector strategy across our international network. As with our
UK transactional income, we anticipate income levels improving as
we move through the year, following on from softer invoicing on the
continent in the first quarter.
We have made good progress in 2023
and the early part of 2024 in strengthening our finance and
insurance brokerage capabilities, and we have continued a strong
level of recovery in our hospitality stock audit business with
further growth expected.
We took decisive action in the
second half of 2023 to address the cost base in our UK retail
stocktaking operation, as well as restructuring our sales team as
we look to move the retail stocktaking components of Orridge into
profit, alongside the already-profitable Pharmacy and Supply Chain
divisions. We have no desire to continue to record operating losses
in that business and we are encouraged by the UK element of our
Orridge operations having recorded an aggregated first-quarter
operating profit in 2024. On the continent, our German operation
continues to derive a strong proportion of its own revenues from Q4
activity.
Our SaaS business began 2024
solidly, with some early new client wins following on from a much
improved 2023 in that respect. Nonetheless, there is more to do.
Our software product has continued to be developed and is
increasingly proving attractive to clients wishing to switch from
competitors choosing to under-invest in their own offering and
where their functionality demands cannot then be met. We do not
anticipate the business unit achieving profitability in 2024, but
if we can achieve a repeat of 2023 in terms of the number and
profile of new clients signed, it would be significant in moving
that ambition onto the horizon.
Dan
Prickett
Chief Executive
26
April 2024
CHIEF FINANCIAL OFFICER'S REVIEW
Undoubtably 2023 was a challenging,
frustrating and ultimately disappointing year for the Group,
following strong progress made in 2021 & 2022 after the impact
of the Covid pandemic.
In 2023, we experienced a sharp
decline in our PFS division transactional volumes particularly in
the first half of 2023, as the impact of continued interest rate
rises together with the inflationary and cost of living pressures
impacted M&A activity. As a result, we endured a significant
reduction in transitional volumes compared to 2022.
Despite the result, the Group
continued to invest in the business and made good progress across a
number of its brands. Moreover, we exited 2023 with positive net
funds, lower borrowings and a strong balance sheet to support our
future growth ambitions.
Income statement
Revenue for the full year decreased
by 4.8% to £65.9m (2022: £69.2m), resulting in an operating loss
pre non-recurring board changes and restructuring costs of £0.6m
(2022: profit £5.5m).
We achieved an improved second half
year performance with an operating profit pre non-recurring board
changes and restructuring costs of £0.8m against a £1.4m operating
loss in the first half.
Compared to 2022 - where certain
businesses in the Group were still impacted by Covid restrictions -
we returned to more normalised levels of travel, marketing &
exhibitions following reduced activity and spend during the
pandemic. This, together with high market driven salary
inflationary levels increased our cost base. Going forward, we
would anticipate that wage growth will return to more controlled
levels in a more normalised inflationary environment.
Cash and net debt
We ended the year with net funds of
£0.6m (2022: £7.2m), measured as cash & cash equivalents less
total borrowings, whilst we reduced overall borrowings by £0.9m to
£0.7m (2022: £1.6m) at the end of 2023.
The significant reduction of net
funds of £6.6m, was attributable to the trading performance from
operating activities, our continued investment in capital
expenditure most notably in terms of continued product investment
and development in our SaaS business, repayment of the final amount
of the CLBILS loan which now leaves us free of any term debt, and
payment of £0.8m of dividends. The Board maintained dividend
payments despite the losses in the year, reflecting the Board's
confidence in the Group's future prospects and resilience to
rebound from what we see as short term market
disruptions.
At the year end, the Group's invoice
discounting facility was £0.7m (2022: £0.6m).
Capital investment
As a Group, we invested £0.9m (2022:
£0.8m) in capital expenditure. As noted above, this
included £0.5m (2022: £0.5m) applied to the
ongoing development of our SaaS visitor attraction software
business. 2023 was a far more positive and encouraging year
in terms of new client wins for our SaaS business, which we believe
endorses our commitment to ongoing development of our product, on
which we fully hold all proprietary rights.
Pension schemes
As a Group, we have endeavoured to
mitigate pension risk exposure with our two defined benefit schemes
closed to new members since 1999 and 2000 respectively. Active
employee membership of those two schemes stands at less than 1% of
our average total number of employees employed, whilst the
remaining eligible employees are members of our defined
contribution schemes.
The pension liability as measured at
the balance sheet date in accordance with IAS 19 & IFRIC 14 was
£0.9m and this has considerably improved over recent years with a
reduction in the liability of over £19.0m since 2020. In fact, at
the balance sheet date there was a surplus of £16.8m in the defined
benefit schemes although accounting standards prevent us from being
able to recognise this.
Moreover, the trustees of both
schemes have made significant investment strategy changes, which
are intended to mitigate the need as fully as possible for the
Group to make further deficit repair payments in the future.
Ongoing cash obligations for the Group should be minimal going
forward, whilst we continue to explore further de-risking
options.
Key
performance indicators (KPIs)
In addition to the non-financial
KPIs included in the Chief Executive report, the principal
financial KPIs for the Group and the individual operating divisions
are set out in the table below.
· Revenue movement
% - is a key indicator that the
Group monitor.
· Operating result
% - an important part of our
strategy is the profitable growth of our businesses and one measure
of this is the operating profit % margin. This is measured as
operating result (pre non-recurring board changes and restructuring
costs) as a percentage of revenue.
· Earnings per share (EPS)
growth - an important part of our
strategy is the growth in our EPS. This is measured both in
absolute terms and year-on-year % growth.
· Net
funds/(debt) - a key metric for the
Group is its cash and debt resources. Net funds/(debt) position is
closely monitored.
· Pension
liability - a key metric for the
Group is the defined benefit pension scheme liability.
KPIs
|
Group
|
PFS
|
SISS
|
Revenue movement (%)
|
|
|
|
2023 on 2022
|
(4.8%)
|
(10.9%)
|
8.4%
|
2022 on 2021
|
13.0%
|
8.2%
|
24.8%
|
2021 on 2020
|
45.1%
|
67.0%
|
9.2%
|
2020 on 2019
|
(45.9%)
|
(43.0%)
|
(50.1%)
|
2019 on 2018
|
2.6%
|
5.9%
|
(1.9%)
|
Operating profit/(loss) as % of revenue
|
Group
|
PFS
|
SISS
|
2023
|
(1.0%)
|
3.2%
|
(8.4%)
|
2022
|
7.9%
|
16.0%
|
(9.7%)
|
2021
|
8.5%
|
17.3%
|
(13.6%)
|
2020
|
(11.9%)
|
(7.1%)
|
(19.8%)
|
2019
|
7.4%
|
13.6%
|
(6.2%)
|
|
|
|
|
|
| |
EPS
(pence)
|
Group
|
YOY mve
|
YOY %
|
2023
|
(14.79p)
|
(27.11p)
|
(220.0%)
|
2022
|
12.32p
|
(1.39p)
|
(10.1%)
|
2021
|
13.71p
|
33.03p
|
171.0%
|
2020
|
(19.32p)
|
(34.62p)
|
(226.3%)
|
2019
|
15.30p
|
4.07p
|
36.2%
|
Net
funds (£'000)
|
Group
|
Movement
|
|
2023
|
615
|
(6,601)
|
|
2022
|
7,216
|
2,617
|
|
2021
|
4,599
|
521
|
|
2020
|
4,078
|
(674)
|
|
2019
|
4,752
|
7,040
|
|
Pension liability (£'000)
|
Group
|
Movement
|
|
2023
|
883
|
70
|
|
2022
|
953
|
8,044
|
|
2021
|
8,997
|
11,139
|
|
2020
|
20,136
|
(8,125)
|
|
2019
|
12,011
|
2,108
|
|
Group
At a Group level, it was a
disappointing year against the KPIs. Revenue decreased by 4.8%,
following a 13.0% increase in 2022. Net funds remain positive at
£0.6m, however this was a significant reduction on 2022 position of
£7.2m. Encouragingly, the two defined pension benefit schemes
remain in surplus and the pension liability has significantly
reduced by £11.1m in the period listed above, which has
significantly strengthened the balance sheet.
PFS
In the PFS division, revenue
decreased by 10.9% following a sharp decline in M&A activity
particularly in the first half of 2023. Operating profit margin
fell to 3.2%. Our ambitions for the division remain unaltered;
profitable growth through the strategic expansion of our service
offerings where we can replicate our UK business models and
services while remaining focused on our specialist sectors. The
investment we have made and continue to make has created an
international infrastructure, capacity and operational gearing
which make improvement of these KPIs a realistic
objective.
SISS
As noted in the preceding Chief
Executive review, the SISS division performance had an improved
performance particularly in our Hospitality stock audit &
consultancy business and our Pharmacy & Supply Chain divisions,
with year-on-year revenue growth in the SISS division of
8.4%.
Taxation
The absolute tax position for the
year was a credit of £0.5m (2022: charge £1.2m), principally as a
result of the loss for the year. In addition, we have unutilised
tax losses to carry forward which will benefit future years income
statement and cashflow.
Deferred tax asset increased in the
year to £2.1m (2022: £1.6m) and this is principally reflective of
losses during the year.
Earnings per share (EPS)
Given the loss for the full year,
EPS was negative at (14.79p). However, the Board believe that with
the progress we have made in 2023 across a number of our brands,
together with the increased activity in the second half of the
year, should permit the Group to return to more normalised EPS
levels going forward.
Simon Hawkins
Chief Financial Officer
26
April 2024
CONSOLIDATED INCOME STATEMENT
For the year ended 31 December 2023
|
|
2023
£'000
|
2022
£'000
|
Revenue
|
|
65,873
|
69,192
|
Other income - government
grants
|
|
-
|
34
|
Employee benefit expenses
|
|
(47,769)
|
(47,390)
|
|
|
18,104
|
21,836
|
Other operating expenses
|
|
(18,736)
|
(16,384)
|
Operating (loss)/profit pre non-recurring
board changes and restructuring costs
|
|
(632)
|
5,452
|
Non-recurring board changes and
restructuring costs
|
|
(2,723)
|
-
|
Operating (loss)/profit post non-recurring board changes and
restructuring costs
|
|
(3,355)
|
5,452
|
Finance costs
|
|
(1,043)
|
(1,077)
|
Finance income
|
|
115
|
49
|
Total finance costs
|
|
(928)
|
(1,028)
|
(Loss)/profit before tax
|
|
(4,283)
|
4,424
|
Taxation
|
|
484
|
(1,213)
|
(Loss)/profit after tax
|
|
(3,799)
|
3,211
|
|
|
|
|
Earnings per share
|
|
|
|
Basic
|
|
(14.79)
|
12.32
|
Diluted
|
|
(14.79)
|
12.15
|
|
|
|
| |
All amounts derive from continuing
activities.
All profit after tax is attributable
to the equity shareholders of the parent.
The accompanying notes are an
integral part of these preliminary results.
CONSOLIDATED STATEMENT OF COMPREHENSIVE
INCOME
For the year ended 31 December
2023
|
|
2023
£'000
|
2022
£'000
|
(Loss)/profit after tax
|
|
(3,799)
|
3,211
|
|
|
|
|
|
Other comprehensive income:
|
|
|
|
Items that may be reclassified subsequently to profit or
loss:
|
|
|
|
Exchange differences on translating
foreign operations
|
|
(42)
|
(119)
|
Net
other comprehensive loss to be reclassified to profit or loss in
subsequent years
|
|
(42)
|
(119)
|
|
|
|
|
|
Items that will not be reclassified subsequently to profit or
loss:
|
|
|
|
Actuarial gains on defined benefit
plans
|
|
2,892
|
20,616
|
Effect of asset ceiling
|
|
(2,882)
|
(13,896)
|
|
|
10
|
6,720
|
Income tax effect on defined benefit
plans
|
|
(723)
|
(3,759)
|
Income tax effect of asset
ceiling
|
|
721
|
1,748
|
|
|
(2)
|
(2,011)
|
Net
other comprehensive income not being reclassified to profit or loss
in subsequent years
|
|
8
|
4,709
|
Other comprehensive (loss)/income for the year net of
tax
|
|
(34)
|
4,590
|
Total comprehensive (loss)/income for the
year
|
|
(3,833)
|
7,801
|
|
|
|
|
| |
Total comprehensive income is
attributable to the equity shareholders of the parent.
The accompanying notes are an
integral part of these preliminary results.
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS'
EQUITY
As at 31 December 2023
For
the year ended 31 December 2022
|
Share
capital
£'000
|
Other
reserves
£'000
|
Cumulative
translation reserve
£'000
|
Retained
earnings
£'000
|
Total
equity £'000
|
Balance at 1 January 2022
|
531
|
5,246
|
686
|
(4,906)
|
1,557
|
Profit for the year after
tax
|
-
|
-
|
-
|
3,211
|
3,211
|
Other comprehensive
(loss)/income
|
-
|
-
|
(119)
|
4,709
|
4,590
|
Total comprehensive (loss)/income for the
year
|
-
|
-
|
(119)
|
7,920
|
7,801
|
Movement in respect of employee
share scheme
|
-
|
(184)
|
-
|
-
|
(184)
|
Employee share option
scheme
|
|
|
|
|
|
- value of services
provided
|
-
|
66
|
-
|
-
|
66
|
Dividends paid
|
-
|
-
|
-
|
(844)
|
(844)
|
Transactions with
shareholders
|
-
|
(118)
|
-
|
(844)
|
(962)
|
|
|
|
|
|
|
Balance at 31 December 2022
|
531
|
5,128
|
567
|
2,170
|
8,396
|
For
the year ended 31 December 2023
|
Share
capital
£'000
|
Other
reserves
£'000
|
Cumulative
translation reserve
£'000
|
Retained
earnings
£'000
|
Total
equity £'000
|
Balance at 1 January 2023
|
531
|
5,128
|
567
|
2,170
|
8,396
|
(Loss)/profit for the year after
tax
|
-
|
-
|
-
|
(3,799)
|
(3,799)
|
Other comprehensive
(loss)/income
|
-
|
-
|
(42)
|
8
|
(34)
|
Total comprehensive (loss)/income for the
year
|
-
|
-
|
(42)
|
(3,791)
|
(3,833)
|
Movement in respect of employee
share scheme
|
-
|
(571)
|
-
|
-
|
(571)
|
Employee share option
scheme
|
|
|
|
|
|
- value of services
provided
|
-
|
76
|
-
|
-
|
76
|
Dividends paid
|
-
|
-
|
-
|
(767)
|
(767)
|
Transfer from share option
reserve
|
-
|
(954)
|
-
|
954
|
-
|
Transactions with
shareholders
|
-
|
(1,449)
|
-
|
187
|
(1,262)
|
|
|
|
|
|
|
Balance at 31 December 2023
|
531
|
3,679
|
525
|
(1,434)
|
3,301
|
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
At 31 December 2023
|
|
|
|
2023
£'000
|
2022
£'000
|
Assets
|
|
|
|
|
|
Non-current assets
|
|
|
|
|
|
Intangible assets -
Goodwill
|
|
|
|
1,826
|
1,843
|
Intangible assets - Other
|
|
|
|
1,249
|
1,104
|
Property, plant and
equipment
|
|
|
|
1,013
|
1,178
|
Right of use assets
|
|
|
|
6,294
|
6,397
|
Deferred tax assets
|
|
|
|
2,102
|
1,565
|
Other receivables
|
|
|
|
2,984
|
2,811
|
|
|
|
|
15,468
|
14,898
|
Current assets
|
|
|
|
|
|
Inventories
|
|
|
|
17
|
25
|
Trade and other
receivables
|
|
|
|
9,442
|
9,349
|
Other current assets
|
|
|
|
3,186
|
3,088
|
Current tax assets
|
|
|
|
-
|
238
|
Cash and cash equivalents
|
|
|
|
1,336
|
8,839
|
|
|
|
|
13,981
|
21,539
|
Total assets
|
|
|
|
29,449
|
36,437
|
|
|
|
|
|
|
Equity
|
|
|
|
Share capital
|
|
|
|
531
|
531
|
Other reserves
|
|
|
|
3,679
|
5,128
|
Cumulative translation
reserve
|
|
|
|
525
|
567
|
Retained earnings
|
|
|
|
(1,434)
|
2,170
|
Total equity
|
|
|
|
3,301
|
8,396
|
Liabilities
|
|
|
|
|
|
Non-current liabilities
|
|
|
|
|
|
Trade and other payables
|
|
|
|
814
|
620
|
Retirement benefit
obligations
|
|
|
|
883
|
953
|
Lease liabilities
|
|
|
|
8,322
|
8,731
|
Provisions
|
|
|
|
1,243
|
1,383
|
|
|
|
|
11,262
|
11,687
|
Current liabilities
|
|
|
|
|
|
Trade and other payables
|
|
|
|
9,834
|
11,463
|
Lease liabilities
|
|
|
|
1,296
|
1,297
|
Current tax liabilities
|
|
|
|
72
|
840
|
Borrowings
|
|
|
|
721
|
1,623
|
Provisions
|
|
|
|
2,963
|
1,131
|
|
|
|
|
14,886
|
16,354
|
Total liabilities
|
|
|
|
26,148
|
28,041
|
Total equity and liabilities
|
|
|
|
29,449
|
36,437
|
The accompanying notes are an
integral part of these preliminary results.
CONSOLIDATED STATEMENT OF CASH FLOWS
For the year ended 31 December
2023
|
|
2023
£'000
|
2022
£'000
|
Cash flow from operating activities
|
|
|
|
Cash (used in)/generated from
operations
|
|
(1,809)
|
6,306
|
Interest paid
|
|
(1,043)
|
(975)
|
Tax paid
|
|
(612)
|
(200)
|
Net cash (used in)/generated from
operating activities
|
|
(3,464)
|
5,131
|
Cash flow from investing activities
|
|
|
|
Purchase of property, plant and
equipment
|
|
(368)
|
(334)
|
Proceeds from sale of property,
plant and equipment
|
|
-
|
1
|
Intangible asset
expenditure
|
|
(544)
|
(454)
|
Interest received
|
|
115
|
49
|
Net cash used in investing
activities
|
|
(797)
|
(738)
|
Cash flow from financing activities
|
|
|
|
Repayment of bank loan
|
|
(1,000)
|
(2,000)
|
Net drawdown of invoice
finance
|
|
10
|
55
|
Repayment of lease
liabilities
|
|
(1,565)
|
(925)
|
Dividends paid
|
|
(767)
|
(844)
|
Net cash used in generated financing
activities
|
|
(3,322)
|
(3,714)
|
Net
(decrease)/increase in cash
|
|
(7,583)
|
679
|
Cash and cash equivalents at
beginning of year
|
|
8,839
|
8,167
|
Exchange gains on euro bank
accounts
|
|
(8)
|
(7)
|
Cash and cash equivalents at end of year
|
|
1,248
|
8,839
|
The accompanying notes are an
integral part of these preliminary results.
NOTES TO THE PRELIMINARY ANNOUNCEMENT
1. BASIS OF PREPARATION
The financial information set out in
this announcement does not comprise the Company's statutory
accounts for the years ended 31 December 2023 or 31 December 2022.
The financial information has been
extracted from the statutory accounts of the Company for the years
ended 31 December 2023 and 31 December 2022. The auditors reported
on those accounts; their reports were unqualified.
The statutory accounts for the year
ended 31 December 2022 have been delivered to the Registrar of
Companies, whereas those for the year ended 31 December 2023 will
be delivered to the Registrar of Companies following the Company's
Annual General Meeting.
While the financial information
included in this preliminary announcement has been prepared in
accordance with the recognition and measurement criteria of
International Financial Reporting Standards (IFRSs), this
announcement does not itself contain sufficient information to
comply with IFRSs. The Company expects to publish full financial
statements that comply with IFRSs in June 2023.
These policies have been
consistently applied to all years presented, unless otherwise
stated.
2. SEGMENT INFORMATION
The Group is organised into three
main operating segments: Professional & Financial
Services (PFS), Stock & Inventory Systems & Services (SISS)
and Other.
The segment results for the year
ended 31 December 2023 are as follows:
|
PFS
£'000
|
SISS
£'000
|
Other
£'000
|
Group
£'000
|
Total gross segment sales
|
42,351
|
23,638
|
-
|
65,989
|
Inter-segment sales
|
(116)
|
-
|
-
|
(116)
|
Revenue
|
42,235
|
23,638
|
-
|
65,873
|
Operating profit/(loss) pre non-recurring board changes and
restructuring costs
|
1,345
|
(1,977)
|
-
|
(632)
|
Non-recurring board changes and
restructuring costs
|
(314)
|
(262)
|
(2,147)
|
(2,723)
|
Operating profit/(loss) post non-recurring board changes and
restructuring costs
|
1,031
|
(2,239)
|
(2,147)
|
(3,355)
|
Finance costs
|
(530)
|
(252)
|
(146)
|
(928)
|
Profit/(loss) before tax
|
501
|
(2,491)
|
(2,293)
|
(4,283)
|
Taxation
|
|
|
|
484
|
Loss
for the year after tax
|
|
|
|
(3,799)
|
The segment results for the year
ended 31 December 2022 are as follows:
|
PFS
£'000
|
SISS
£'000
|
Other
£'000
|
Group
£'000
|
Total gross segment sales
|
47,487
|
21,815
|
-
|
69,302
|
Inter-segment sales
|
(110)
|
-
|
-
|
(110)
|
Revenue
|
47,377
|
21,815
|
-
|
69,192
|
Operating profit/(loss)
|
7,570
|
(2,118)
|
-
|
5,452
|
Finance costs
|
(554)
|
(292)
|
(182)
|
(1,028)
|
Profit/(loss) before tax
|
7,016
|
(2,410)
|
(182)
|
4,424
|
Taxation
|
|
|
|
(1,213)
|
Profit for the year after tax
|
|
|
|
3,211
|
Revenue is allocated below based on
the entity's country of domicile.
|
2023
£'000
|
2022
£'000
|
Revenue
|
|
|
Europe
|
65,862
|
69,176
|
Rest of the World
|
11
|
16
|
|
65,873
|
69,192
|
3. DIVIDENDS
A final dividend in respect of the
year ended 31 December 2023 of 0.50p per share (2022: 2.50p),
amounting to a payment of £126,000 (2022: £663,000) is to be
proposed at the Annual General Meeting on 13 June 2024.
In the year the Group paid an
interim dividend of 0.50p per share (2022: 1.25p) totalling
£126,000 (2022: £324,000).
4. EARNINGS PER SHARE
Basic earnings per share is
calculated by dividing the profit attributable to equity holders of
the Company by the weighted average number of ordinary shares in
issue during the year, which excludes the shares held in the
Employee Share Ownership Plan (ESOP) trust.
|
2023
£'000
|
2022
£'000
|
(Loss)/profit attributable to equity
holders of the Company
|
(3,799)
|
3,211
|
|
Thousands
|
Thousands
|
Weighted average number of ordinary
shares in issue
|
25,694
|
26,062
|
Adjustment for share
options
|
235
|
361
|
Weighted average number of ordinary
shares for diluted earnings per share
|
25,929
|
26,423
|
|
Pence
|
Pence
|
Basic earnings per share
|
(14.79)
|
12.32
|
Diluted earnings per
share
|
(14.79)
|
12.15
|
5. NOTES TO THE CASH FLOW
STATEMENT
Cash generated from operations
|
2023
£'000
|
2022
£'000
|
(Loss)/profit for the year after
tax
|
(3,799)
|
3,211
|
Adjustments for:
|
|
|
Taxation
|
(484)
|
1,213
|
Finance costs
|
928
|
1,028
|
Depreciation
|
1,591
|
1,463
|
Amortisation of intangible
assets
|
399
|
388
|
(Loss)/profit on sale of property,
plant and equipment
|
(64)
|
-
|
Increase in provisions
|
1,692
|
62
|
Payments to ESOT
|
(375)
|
(284)
|
Foreign currency
translation
|
88
|
(437)
|
Share option charge
|
76
|
66
|
Movement in non-current other
receivables
|
(173)
|
(256)
|
Movement in working
capital:
|
|
|
Decrease/(increase) in
inventories
|
8
|
(10)
|
(Increase)/decrease in trade and
other receivables
|
(191)
|
65
|
Decrease in trade and other
payables
|
(1,505)
|
(203)
|
Cash
(used in)/generated from operations
|
(1,809)
|
6,306
|
Report and Accounts
Copies of the 2023 Annual Report and
Accounts will be posted to shareholders in May. Further
copies may be obtained by contacting the Company Secretary at the
registered office. Alternatively, the 2023 Annual Report and
Accounts will be available to download from the investors section
on the Company's website www.christiegroup.com
Key
dates
The Annual General Meeting of the
Company is scheduled to take place at 10.00am on Thursday 13 June
2024 at Whitefriars House, 6 Carmelite Street, London, EC4Y
0BS.
Group Companies
Professional
& Financial
Services
Christie & Co
Christie & Co is the leading
specialist firm providing business intelligence in the hospitality,
leisure, healthcare, medical, childcare & education and retail
sectors. A leader in its specialist markets, it employs the largest
team of sector experts in the UK & Europe providing
professional agency, valuation and consultancy
services.
Christie Finance
Christie Finance has 45 years'
experience in financing businesses in the hospitality, leisure,
healthcare, medical, childcare & education, retail and medical
sectors. Christie Finance prides itself on its speed of response to
client opportunities and its strong relationships with finance
providers.
Christie Insurance
Christie Insurance has over 45
years' experience arranging business insurance in the hospitality,
leisure, healthcare, medical, childcare & education and retail
sectors. It delivers and exceeds clients' expectations in terms of
the cost of their insurance and the breadth of its
cover.
Pinders
Pinders is the UK's leading
specialist business appraisal, valuation and consultancy company,
providing professional services to the licensed, leisure, retail
and care sectors, and also the commercial and corporate business
sectors. Its Building Consultancy Division offers a full range of
project management, building monitoring and building surveying
services. Pinders staff use business analysis and surveying skills
to look at the detail of the businesses to arrive at accurate
assessments of their trading potential and value.
www.pinders.co.uk
Stock & Inventory Systems &
Services
Orridge
Orridge is Europe's longest
established stocktaking business specialising in a range of valued
services to the Retail and Pharmacy sections, and supply chain
auditing services that elevate customers' operations where they are
concentrated. Its specialised pharmacy business provides
trusted valuation and stocktaking services throughout the
healthcare sector. Orridge prides itself in its ability to produce
dependable data and deliver high-quality management information to
its clients, effectively and conveniently.
www.orridge.eu
Venners
Venners is the leading supplier of stocktaking, inventory,
consultancy & compliance services and related stock management
systems to the hospitality sector. Consultancy & compliance
services include control audits and live event stock taking.
Bespoke software and systems enable real-time management reporting
to customers using the best available technologies. Venners is the
largest and longest established stock audit company in the sector
in the UK.
www.venners.com
Vennersys
Vennersys operates in the UK and deliveries online cloud-based
ticketing sales and admission systems to visitor attractions such
as historic houses and estates, museums, zoos, safari parks,
aquaria and cinemas. It has over 30 years' experience delivering
purpose-designed solutions for clients' ticketing, admissions, EPoS
and food and beverages sales requirements.
www.vennersys.co.uk